ValuEngine upgraded shares of Omega Protein (NYSE:OME) from a hold rating to a buy rating in a research report report published on Friday.

Omega Protein (NYSE:OME) traded up $0.05 during trading on Friday, reaching $22.00. 305,478 shares of the company traded hands, compared to its average volume of 563,623. Omega Protein has a 12-month low of $14.50 and a 12-month high of $26.99. The firm has a market cap of $493.41, a P/E ratio of 22.17 and a beta of 0.28.

Omega Protein (NYSE:OME) last posted its quarterly earnings results on Wednesday, November 8th. The company reported $0.09 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.31 by ($0.22). The business had revenue of $90.30 million during the quarter, compared to analyst estimates of $96.65 million. Omega Protein had a return on equity of 6.48% and a net margin of 5.45%. The business’s revenue was down 17.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.67 EPS.

Several large investors have recently bought and sold shares of OME. Macquarie Group Ltd. acquired a new position in shares of Omega Protein in the third quarter worth $113,000. Victory Capital Management Inc. lifted its position in shares of Omega Protein by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 9,234 shares of the company’s stock worth $165,000 after purchasing an additional 1,384 shares during the last quarter. AHL Partners LLP purchased a new stake in shares of Omega Protein during the 2nd quarter worth $189,000. Voya Investment Management LLC lifted its position in shares of Omega Protein by 16.2% during the 2nd quarter. Voya Investment Management LLC now owns 11,668 shares of the company’s stock worth $209,000 after purchasing an additional 1,626 shares during the last quarter. Finally, UBS Group AG lifted its position in shares of Omega Protein by 191.6% during the 1st quarter. UBS Group AG now owns 12,575 shares of the company’s stock worth $252,000 after purchasing an additional 8,262 shares during the last quarter. Institutional investors and hedge funds own 86.04% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Omega Protein (OME) Upgraded to Buy by ValuEngine” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/12/02/omega-protein-ome-upgraded-to-buy-by-valuengine.html.

Omega Protein Company Profile

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).

Receive News & Stock Ratings for Omega Protein Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein Corporation and related stocks with our FREE daily email newsletter.